Efficacy and Safety of LY333334 in Japanese Patients With Osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 15 Sep 2014
At a glance
- Drugs Teriparatide (Primary)
- Indications Fracture; Osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 19 Oct 2010 Results presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research.
- 03 Nov 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History